Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus–specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell–based therapeutic strategies for HIV.
Rachel L. Rutishauser, Christian Deo T. Deguit, Joseph Hiatt, Franziska Blaeschke, Theodore L. Roth, Lynn Wang, Kyle A. Raymond, Carly E. Starke, Joseph C. Mudd, Wenxuan Chen, Carolyn Smullin, Rodrigo Matus-Nicodemos, Rebecca Hoh, Melissa Krone, Frederick M. Hecht, Christopher D. Pilcher, Jeffrey N. Martin, Richard A. Koup, Daniel C. Douek, Jason M. Brenchley, Rafick-Pierre Sékaly, Satish K. Pillai, Alexander Marson, Steven G. Deeks, Joseph M. McCune, Peter W. Hunt
Title and authors | Publication | Year |
---|---|---|
Persistent elite controllers as the key model to identify permanent HIV remission
Gasca-Capote C, Ruiz-Mateos E |
Current Opinion in HIV and AIDS | 2025 |
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Laeremans T, Janssens A, Aerts JL |
Immunotherapy | 2025 |
Combination immunotherapy induces post-intervention control of HIV
Peluso MJ, Sandel DA, Deitchman AN, Kim SJ, Dalhuisen T, Tummala HP, Tibúrcio R, Zemelko L, Borgo GM, Singh SS, Schwartz K, Deswal M, Williams MC, Hoh R, Shimoda M, Narpala S, Serebryannyy L, Khalili M, Vendrame E, SenGupta D, Whitmore LS, Tisoncik-Go J, Gale M Jr, Koup RA, Mullins JI, Felber BK, Pavlakis GN, Reeves JD, Petropoulos CJ, Glidden DV, Spitzer MH, Gama L, Caskey M, Nussenzweig MC, Chew KW, Henrich TJ, Yukl SA, Cohn LB, Deeks SG, Rutishauser RL |
Research Square | 2025 |
Impact of rosuvastatin on the memory potential and functionality of CD8+ T cells from people with HIV
Perdomo-Celis F, Passaes C, Monceaux V, Lambotte O, Costagliola D, Chevalier MF, Weiss L, Sáez-Cirión A |
eBioMedicine | 2025 |
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection
Preechanukul J, Alrubayyi A, Sun B, Arbe-Barnes E, Kokici J, Gorou F, Prasitdumrong S, da Costa KA, Fisher-Pearson N, Hussain N, Kucykowicz S, Ghosh I, Burns F, Kinloch S, Simoes P, Bhagani S, Kennedy PT, Maini MK, Bashford-Rogers R, Gill US, Peppa D |
medRxiv | 2025 |
Immune-mediated strategies to solving the HIV reservoir problem.
Kulpa DA, Paiardini M, Silvestri G |
Nature reviews. Immunology | 2025 |
AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level
Conceição-Neto N, Pierson W, Han Q, Yao Z, Wu Q, Dockx K, Aerts L, De Maeyer D, Beyens M, den Berge KV, Li C, Kukolj G, Zhu R, Krishna V, Podlaha O, Nájera I, Van Gulck E |
Frontiers in Immunology | 2025 |
Understanding the HIV-specific T-cell response to immune checkpoint blockade: what can we learn from cancer immunotherapy?
Gubser C, Kaufmann DE |
Current Opinion in HIV and AIDS | 2025 |